Ralph Fritsch
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 15
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 16
- Colorectal Cancer Treatments and Studies 11
- Cancer Cells and Metastasis 5
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 5
- Immunology top 10%
-
- Lung Cancer Treatments and Mutations 9
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Dieter SaurRoland M. SchmidJulian DownwardGordon StampGünter SchneiderPierre–Alain ClavienHenrik PetrowskyMarkus E. Diefenbacher
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ralph Fritsch
64 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 429
- Oncology 678
- Hepatology 119
- Molecular Biology 903
- Immunology 217
Countries citing papers authored by Ralph Fritsch
This map shows the geographic impact of Ralph Fritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Fritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Fritsch more than expected).
Fields of papers citing papers by Ralph Fritsch
This network shows the impact of papers produced by Ralph Fritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Fritsch. The network helps show where Ralph Fritsch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ralph Fritsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 120 | |
| 11 | 2019 | 90 | |
| 12 | 2018 | 16 | |
| 13 | 2017 | 32 | |
| 14 | 2017 | 67 | |
| 15 | 2016 | 37 | |
| 16 | 2013 | 34 | |
| 17 | 2008 | 73 | |
| 18 | 2007 | 34 | |
| 19 | 2007 | 8 | |
| 20 | 2002 | 4 |
About Ralph Fritsch
Ralph Fritsch is a scholar working on Cancer Research, Oncology and Hepatology, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (15 papers), Colorectal Cancer Treatments and Studies (11 papers), Lung Cancer Treatments and Mutations (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Melanoma and MAPK Pathways (5 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Cancer Research (429 citations), Oncology (678 citations) and Hepatology (119 citations). Ralph Fritsch has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Dieter Saur, Roland M. Schmid, Julian Downward, Gordon Stamp, Günter Schneider, Pierre–Alain Clavien, Henrik Petrowsky, Markus E. Diefenbacher, Madhu Kumar and Matthias Gückenberger. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.